New ETF Book by Larry Connors - Click here to read more
TriValley Corp (AMEX: TIV | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the exploration, acquisition, and development of petroleum, metal, and mineral properties. The company's principal oil and gas properties include the Ekho property and Sunrise-Mayel Natural Gas project located in California. It also holds interests in the Temblor Valley West/South Belridge Field; and Temblor Valley East/Edison Oil Field, which consists of four separate leases in the Edison and Edison Grove Fields comprising 31 wells located in Kern County, California. In addition, the company has interest in the Pleasant Valley property located in Ventura County; and the Moffat Ranch and Chowchilla Ranch gas field in Madera County, California, as well as holds producing interests in gas fields in the Sacramento Valley of northern California, including the Rio Vista and Dutch Slough gas fields. Additionally, it operates precious metals properties in Alaska comprising the Richardson claim block consisting of 28,720 gross acres located in the north of Richardson Highway; and the Shorty Creek project with 11,080 gross acres in the Livengood District of Alaska. Further, the company holds industrial mineral project, which consists of the Admiral calcium carbonate mine located on the north-west side of Prince of Wales Island. It also involves in oil and gas drilling and development operations. Tri-Valley Corporation was founded in 1971 and is headquartered in Bakersfield, California. With 27.01 million shares outstanding and 3.47 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of TIV. According to quarterly data provided by the SEC, there were still 757,449 shares of TIV that were failing-to-deliver as of July 6, 2006.
ArthroCare Corp. (NASDAQ: ARTC | Quote | Chart | News | PowerRating) designs, develops, manufactures, and markets medical devices for use in soft-tissue surgery. Its products are based on the patented soft-tissue surgical controlled ablation technology called Coblation technology. The company offers Coblation-based devices for arthroscopy/sports medicine, spinal surgery, and ear, nose, and throat (ENT) applications. The company's products for sports medicine include Arthroscopic System, which is used to treat various orthopedic conditions, including those involving knees, ankles, elbows, wrists, tendons, and hips. Its spinal surgery products include the DLR, DLG, and DC SpineWand Convenience Packs for minimally invasive disc decompression; MD SpineWand surgical device for microdiscectomy cases; and vertebral access and bone biopsy needles, cement delivery systems, bone cement and opacifiers, and ancillary devices for minimally invasive repair of vertebral compression fractures. The company also provides Plasma Disc Decompression, a minimally invasive disc decompression procedure using Coblation technology to treat symptomatic patients with contained herniated discs. ArthroCare's ENT products include suction wands that simultaneously ablate and remove tissue in applications, such as tonsillectomy; channeling wands for controlled ablation and coagulative lesion formation in applications, such as turbinate reduction to relieve nasal obstruction and stiffening of the soft palate for the treatment of snoring; and excision wands that provide precise dissection of soft tissue with minimal damage to surrounding tissue. The company markets and sells its products using a combination of distributors, direct sales force, and corporate partners primarily in the Americas, the United Kingdom, and Germany. ArthroCare Corporation was founded in 1993 and is headquartered in Austin, Texas. With 26.63 million shares outstanding and 13.46 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of ARTC. According to quarterly data provided by the SEC, there were still 3,336,871 shares of ARTC that were failing-to-deliver as of February 14, 2008.
Beacon Power Corp. (NASDAQ: BCON | Quote | Chart | News | PowerRating) designs, develops, and commercializes advanced products and services to support stable and reliable electricity grid operation in the United States. The company is focusing on commercializing its patented flywheel energy storage technology to perform frequency regulation services on the grid. Its Smart Energy Matrix is in production following approval for use in three of the country's five open-bid regulation markets. Smart Energy Matrix is designed to be a non-polluting, megawatt-level, and utility-grade flywheel-based solution for providing sustainable frequency regulation services. The company operates a research, development, and manufacturing facility in the country. Beacon Power was founded in 1997 and is headquartered in Tyngsboro, Massachusetts. With 88.75 million shares outstanding and 10.22 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of BCON. According to quarterly data provided by the SEC, there were still 3,623,527 shares of BCON that were failing-to-deliver as of March 21, 2006.
BonTon Stores Inc. (NASDAQ: BONT | Quote | Chart | News | PowerRating) through its subsidiaries, operates department stores in the mid-size and metropolitan markets of the United States. Its stores offer brand-name fashion apparel and accessories for women, men, and children, as well as footwear, cosmetics, home furnishings, intimate apparel, and juniors' apparel. As of February 2, 2008, it operated 280 stores in 23 Northeastern, Midwestern, and upper Great Plains states under the Bon-Ton, Bergner's, Boston Store, Carson Pirie Scott, Elder-Beerman, Herberger's, Younkers, and Parisian names. The company was founded in 1898 and is headquartered in York, Pennsylvania. With 17.7 million shares outstanding and 4.1 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of BONT. According to quarterly data provided by the SEC, there were still 512,819 shares of BONT that were failing-to-deliver as of January 14, 2008.
Cathay General Bancorp (NASDAQ: CATY | Quote | Chart | News | PowerRating) operates as the holding company for Cathay Bank, which offers various financial services for individuals, professionals, and small to medium-sized businesses primarily in California. Its deposit products include passbook accounts, checking accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, college certificates of deposit, and public funds deposits. The company provides various loan products, such as commercial mortgage loans, commercial loans, small business administration loans, residential mortgage loans, real estate construction loans, and equity lines of credit; and installment loans to individuals for automobile, household, and other consumer expenditures. In addition, it provides letters of credit, wire transfers, forward currency spot and forward contracts, traveler's checks, safe deposit, night deposit, social security payment deposit, collection, bank-by-mail, drive-up and walk-up windows, automatic teller machines, Internet banking services, and other customary bank services. As of December 31, 2007, Cathay General Bancorp had 21 branches in Southern California, 10 branches in Northern California, 9 branches in New York, 1 branch in Massachusetts, 2 branches in Texas, 3 branches in Washington, 3 branches in Illinois, 1 branch in New Jersey, and 1 branch in Hong Kong, as well as a representative office in Shanghai and Taipei. The company was founded in 1961 and is based in Los Angeles, California. With 49.47 million shares outstanding and 13.6 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of CATY. According to quarterly data provided by the SEC, there were still 790,654 shares of CATY that were failing-to-deliver as of April 11, 2008.
Cell Genesys Inc. (NASDAQ: CEGE | Quote | Chart | News | PowerRating) a biotechnology company, engages in the development and commercialization of biological therapies for patients with cancer. It develops cell-based cancer immunotherapies and oncolytic virus therapies. The company's GVAX cancer Immunotherapies comprise Prostate Cancer, a phase III product for the treatment of prostate cancer; Pancreatic Cancer, a phase II product for pancreatic cancer; and Leukemia, a phase II product for the treatment of acute and chronic myelogenous leukemia, and myelodysplastic syndrome. Its Oncolytic Virus Therapy includes CG0070, a phase I product for the treatment of recurrent bladder cancer. Cell Genesys has alliance with Novartis AG for the development and commercialization of oncolytic virus therapies; research and development collaboration with Medarex, Inc.; and development and commercialization collaboration of GVAX immunotherapy with Takeda Pharmaceutical Company Limited for prostate cancer. The company was founded in 1988 and is headquartered in South San Francisco, California. With 85.9 million shares outstanding and 17.72 million shares declared short as of September 2008, there is no longer a failure to deliver in shares of CEGE. According to quarterly data provided by the SEC, there were still 2,577,329 shares of CEGE that were failing-to-deliver as of April 10, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,200,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. TIV has previously paid a $995.00 data fee to BUYINS.NET. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
